Welcome to LookChem.com Sign In|Join Free

CAS

  • or

150691-04-6

Post Buying Request

150691-04-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

150691-04-6 Usage

Description

2-(tert-Butylamino)sulfonylphenylboronic acid is a boronic acid derivative with the molecular formula C10H16BNO4S. It features a boron atom attached to a phenyl ring and a sulfonamide group, with a tert-butylamino group providing steric hindrance at the boron center. 2-(tert-Butylamino)sulfonylphenylboronic acid is known for its reactivity and stability in organic synthesis, particularly in forming carbon-carbon and carbon-heteroatom bonds.

Uses

Used in Organic Synthesis:
2-(tert-Butylamino)sulfonylphenylboronic acid is used as a reagent in organic synthesis for the formation of carbon-carbon and carbon-heteroatom bonds. Its unique structure and reactivity make it a valuable component in creating complex organic molecules.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 2-(tert-Butylamino)sulfonylphenylboronic acid is used as a building block or intermediate in the synthesis of various drug candidates. Its potential applications include the development of new therapeutic agents and the improvement of existing medications.
Used as a Ligand in Catalytic Reactions:
2-(tert-Butylamino)sulfonylphenylboronic acid is utilized as a ligand in catalytic reactions, enhancing the efficiency and selectivity of various chemical transformations. Its presence can improve the performance of catalysts and facilitate specific reaction pathways.
Used in Optoelectronic Materials Development:
In the optoelectronics industry, 2-(tert-Butylamino)sulfonylphenylboronic acid is used in the development of materials for optoelectronic devices. Its properties contribute to the creation of advanced materials with improved performance in areas such as solar cells, light-emitting diodes, and photodetectors.

Check Digit Verification of cas no

The CAS Registry Mumber 150691-04-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,0,6,9 and 1 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 150691-04:
(8*1)+(7*5)+(6*0)+(5*6)+(4*9)+(3*1)+(2*0)+(1*4)=116
116 % 10 = 6
So 150691-04-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H16BNO4S/c1-10(2,3)12-17(15,16)9-7-5-4-6-8(9)11(13)14/h4-7,12-14H,1-3H3

150691-04-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (2-(N-(tert-Butyl)sulfamoyl)phenyl)boronic acid

1.2 Other means of identification

Product number -
Other names [2-(tert-butylsulfamoyl)phenyl]boronic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:150691-04-6 SDS

150691-04-6Relevant articles and documents

BENZOXAZEPIN COMPOUNDS SELECTIVE FOR PI3K P110 DELTA AND METHODS OF USE

-

, (2012/10/08)

Benzoxazepin Formula I compounds, including stereoisomers, geometric isomers, tautomers, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting the delta isoform of PI3K, and for treating disorders mediated by lipid kinases such as inflammation, immunological disorders, and cancer. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

Design and synthesis of cyclic sulfonamides and sulfamates as new calcium sensing receptor agonists

Kiefer, Lionel,Gorojankina, Tatiana,Dauban, Philippe,Faure, Hélène,Ruat, Martial,Dodd, Robert H.

scheme or table, p. 7483 - 7487 (2011/02/21)

The design, synthesis and calcimimetic properties of various cyclic sulfonamides and sulfamates are described. The latter were prepared from the corresponding o-alkenylarenesulfonamides via copper- or rhodium-catalyzed intramolecular aziridination. The si

THIOUREAS AS FACTOR Xa INHIBITORS

-

Page/Page column 45, (2010/11/08)

The present invention is directed to compounds represented by Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to and intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 150691-04-6